UBS ASSET MANAGEMENT AMERICAS LLC - FULCRUM THERAPEUTICS INC ownership

FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 111 filers reported holding FULCRUM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.6%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of FULCRUM THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$73,2420.0%25,6990.0%0.00%
Q1 2023$73,242
-32.0%
25,699
+73.6%
0.00%
Q4 2022$107,744
-99.9%
14,8000.0%0.00%
Q3 2022$119,732,000
+65.1%
14,8000.0%0.00%
Q2 2022$72,520,000
-79.3%
14,8000.0%0.00%
Q1 2022$350,020,00014,8000.00%
Other shareholders
FULCRUM THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
TRV GP III, LLC 3,962,202$32,054,00014.00%
TRV GP IV, LLC 2,343,154$18,956,00011.08%
Logos Global Management LP 1,950,000$15,776,0001.94%
COWEN AND COMPANY, LLC 2,347,989$18,995,0001.82%
VR Adviser, LLC 1,200,000$9,708,0001.50%
RA Capital Management 7,000,000$56,630,0001.21%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,528,000$28,542,0001.18%
ACUTA CAPITAL PARTNERS, LLC 220,000$1,780,0000.77%
RTW INVESTMENTS, LP 3,985,910$32,246,0000.74%
BRANDYWINE MANAGERS, LLC 26,127$211,0000.69%
View complete list of FULCRUM THERAPEUTICS INC shareholders